Skip to main content
. 2017;88(4):435–444. doi: 10.23750/abm.v88i4.6837

Table 3.

Medications used in thalassemic patients with hypoparathyroidism

Medications n. (%)
1,25-dihydroxyvitamin D3 159 (66.5%)
1-hydroxy-vitamin D3 63 (26.3%)
Dihydrotachysterol 8 (3.3%)
Calcium carbonate 191 (79.9%)
Calcium citrate 5 (2%)
Low phosphate diet 142 (59.4%)
Teriparatide 1 (0.48%)
Others none